METHOTREXATE-INDUCED RENAL-FAILURE AND INEFFECTIVENESS OF PERITONEAL-DIALYSIS

[1] BENDER RA, 1975, NEW ENGL J MED, V292, P432

[2] BERTINO J R, 1964, Methods Med Res, V10, P297

[3] METHOTREXATE - CLINICAL PHARMACOLOGY, CURRENT STATUS AND THERAPEUTIC GUIDELINES [J]. CANCER TREATMENT REVIEWS, 1977, 4 (02) : 87 - 101

[4] CONDIT PT, 1969, CANCER, V23, P126, DOI 10.1002/1097-0142(196901)23:1<126::AID-CNCR2820230115>3.0.CO

[5] 2-#

[6] DAVIDSON WD, 1977, AM SOC ARTIF INTERN, V6, P16

[7] DJERASSI I, 1977, CANCER TREAT REP, V61, P751

[8] JACOBS SA, 1976, P AM ASSOC CANC RES, V17, P23

[9] JAFFE N, 1972, CANCER-AM CANCER SOC, V30, P1627, DOI 10.1002/1097-0142(197212)30:6<1627::AID-CNCR2820300631>3.0.CO

[10] 2-H

[1] BENDER RA, 1975, NEW ENGL J MED, V292, P432

[2] BERTINO J R, 1964, Methods Med Res, V10, P297

[3] METHOTREXATE - CLINICAL PHARMACOLOGY, CURRENT STATUS AND THERAPEUTIC GUIDELINES [J]. CANCER TREATMENT REVIEWS, 1977, 4 (02) : 87 - 101

[4] CONDIT PT, 1969, CANCER, V23, P126, DOI 10.1002/1097-0142(196901)23:1<126::AID-CNCR2820230115>3.0.CO

[5] 2-#

[6] DAVIDSON WD, 1977, AM SOC ARTIF INTERN, V6, P16

[7] DJERASSI I, 1977, CANCER TREAT REP, V61, P751

[8] JACOBS SA, 1976, P AM ASSOC CANC RES, V17, P23

[9] JAFFE N, 1972, CANCER-AM CANCER SOC, V30, P1627, DOI 10.1002/1097-0142(197212)30:6<1627::AID-CNCR2820300631>3.0.CO

[10] 2-H